Alterity Therapeutics Limited
ATHE
$3.43
-$0.02-0.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 32.82M | 32.54M | 26.66M | 25.36M | 2.81M |
| Total Receivables | 4.56M | 4.53M | 2.58M | 2.46M | 3.52M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 808.40K | 769.10K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 520.30K | 515.90K | 27.40K | 26.10K | 130.30K |
| Total Current Assets | 37.90M | 37.58M | 30.07M | 28.61M | 6.46M |
|
|
|||||
| Total Current Assets | 37.90M | 37.58M | 30.07M | 28.61M | 6.46M |
| Net Property, Plant & Equipment | 64.00K | 63.40K | 101.70K | 96.80K | 71.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 37.97M | 37.65M | 30.18M | 28.71M | 6.53M |
|
|
|||||
| Total Accounts Payable | 1.06M | 1.06M | 352.90K | 335.70K | 1.27M |
| Total Accrued Expenses | 627.00K | 621.70K | 1.90M | 1.80M | 363.20K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 22.00K | 21.80K | 43.90K | 41.70K | 38.80K |
| Total Finance Division Other Current Liabilities | 10.70K | 10.60K | 23.40K | 22.20K | 10.70K |
| Total Other Current Liabilities | 10.70K | 10.60K | 23.40K | 22.20K | 10.70K |
| Total Current Liabilities | 1.72M | 1.71M | 2.32M | 2.20M | 1.68M |
|
|
|||||
| Total Current Liabilities | 1.72M | 1.71M | 2.32M | 2.20M | 1.68M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 43.70K | 43.30K | 58.10K | 55.20K | 26.70K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.77M | 1.75M | 2.38M | 2.26M | 1.71M |
|
|
|||||
| Common Stock & APIC | 188.44M | 186.86M | 172.39M | 163.99M | 138.33M |
| Retained Earnings | -156.34M | -155.02M | -148.09M | -140.88M | -136.77M |
| Treasury Stock & Other | 4.09M | 4.06M | 3.50M | 3.33M | 3.26M |
| Total Common Equity | 36.20M | 35.89M | 27.80M | 26.45M | 4.82M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 36.20M | 35.89M | 27.80M | 26.45M | 4.82M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 36.20M | 35.89M | 27.80M | 26.45M | 4.82M |
|
|
|||||